72.11.Z - Research and experimental development on biotechnology
19.20.Z - Manufacture and processing ofrefind petroleum products
46.19.Z - Agents involved in the sale of a variety of goods
46.71.Z - Wholesale of fuels and related products
46.75.Z - Wholesale of chemical products
46.76.Z - Wholesale of other intermediate products
64.19.Z - Other monetary intermediation
64.99.Z - Other financial service activities, except insurance and pension funding not elsewhere classified
70.22.Z - Business and other management consultancy activities
72.19.Z - Other research and experimental development on natural sciences and engineering
2019 | 2020 | ||
---|---|---|---|
M PLN | M PLN | % | |
Net sales | 0 | 1,2 | 3184,5 |
Liabilities and provisions | 0 | 0 | -20,5 |
Equity | 0 | 0,6 | 76 516,9 |
Total assets | 0 | 0,6 | 1108,5 |
Cash and cash equivalents | 0 | 0 | 569,7 |
Depreciation | 0 | 0 | -∞ |
Gross profit / loss | -0,3 | 0,6 | 281,4 |
EBITDA | -0,3 | 0,6 | 278,3 |
Net profit / loss | -0,3 | 0,6 | 281,5 |
Operating profit (EBIT) | -0,3 | 0,6 | 278,2 |
Current assets | 0 | 0,6 | 1087 |
% | % | p.p. | |
Return on equity (ROE) | -42 156,6 | 99,9 | 42 256,5 |
Return on sales (ROS) | -843,3 | 46,6 | 889,9 |
Equity ratio | 1,5 | 93,5 | 92 |
EBITDA margin | -860,6 | 46,7 | 907,3 |
Gross profit margin | -843,9 | 46,6 | 890,5 |
Days | Days | Days | |
Current liabilities turnover ratio | 488 | 12 | -476 |
Current ratio | 1 | 15,1 | 14,1 |
Net debt to EBITDA | -0,1 | -0,1 | 0 |
Opinions regarding services, products, and company activities are not verified. This means that ING Services for Business S.A., as the provider of the Aleo platform, does not ensure that the published opinions come from consumers who have used the product or availed of the company's services. However, we do strive to ensure that opinions do not violate universally applicable laws.